New modalities in antiviral therapy.
D000212:Acyclovir / Q000627:therapeutic use; D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003139:Common Cold / Q000517:prevention & control; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy; D010253:Respirovirus Infections / Q000188:drug therapy; D012254:Ribavirin / Q000627:therapeutic use; D014777:Virus Diseases / Q000517:prevention & control
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons; D000547:Amantadine; D000212:Acyclovir